B. Hirshberg

N. Iqbal, B. Hirshberg, E. Ekholm, 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Postprandial dynamics of plasma glucose, insulin, and glucagon in patients with type 2 diabetes treated with saxagliptin plus dapagliflozin add-on to metformin therapy.

N. Iqbal, B. Hirshberg, E. Ekholm, 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Incidence of Fractures in Patients With Type 2 Diabetes in the SAVOR-TIMI 53 Trial

Deepak L. Bhatt, B. Scirica, I. Raz, 2015, Diabetes Care.

Real-world effectiveness of casirivimab and imdevimab among patients diagnosed with COVID-19 in the ambulatory setting: a retrospective cohort study using a large claims database

V. Mastey, D. Weinreich, J. Jalbert, 2022, BMJ Open.

Safety of saxagliptin: events of special interest in 9156 patients with type 2 diabetes mellitus

N. Iqbal, B. Hirshberg, M. Donovan, 2014, Diabetes/metabolism research and reviews.

Prolonged renal dysfunction secondary to renal-artery stenosis in the elderly--it is never too late.

D. Rubinger, B. Hirshberg, T. Sasson, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A Pooled Analysis of the Efficacy and Safety of Saxagliptin as Monotherapy in Patients with Type 2 Diabetes

N. Iqbal, B. Hirshberg, John Xu, 2015 .

Adding saxagliptin to extended‐release metformin vs. uptitrating metformin dosage

Tong Zhu, V. Fonseca, C. Karyekar, 2012, Diabetes, obesity & metabolism.

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial.

Deepak L. Bhatt, B. Lewis, E. Braunwald, 2015, Circulation.

Non‐linear increase in GLP‐1 levels in response to DPP‐IV inhibition in healthy adult subjects

B. Hirshberg, G. Preston, S. Gustavson, 2008, Diabetes, obesity & metabolism.

Pancreatic perfusion of healthy individuals and type 1 diabetic patients as assessed by magnetic resonance perfusion imaging

R. Sherwin, A. Cali, M. Tal, 2009, Diabetologia.

Implications of the 2008 update from the collaborative islet transplant registry

B. Hirshberg, 2009, Current diabetes reports.

Pulmonary Angiography for the Diagnosis of Thromboembolic Events in the Non-Human Primate

D. Harlan, B. Wood, Z. Neeman, 2004, Transplantation.

Incidence of Pancreatitis and Pancreatic Cancer in a Randomized Controlled Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin

Deepak L. Bhatt, M. Lerch, B. Scirica, 2014, Diabetes Care.

Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft

D. Harlan, K. Rother, Z. Neeman, 2009, Diabetologia.

Efficacy, safety, and mechanistic insights of cotadutide a dual receptor glucagon-like peptide-1 and glucagon agonist.

T. Heise, J. Meier, P. Ambery, 2020, The Journal of clinical endocrinology and metabolism.

Sirolimus-induced interstitial pneumonitis in an islet transplant recipient.

D. Harlan, K. Rother, B. Hirshberg, 2003, Diabetes care.

Saxagliptin Responder Analysis: A Pooled Analysis of 5 Clinical Trials

G. Leibowitz, N. Iqbal, B. Hirshberg, 2016 .

Can statins reduce the incidence of new-onset diabetes post transplantation?

B. Hirshberg, 2005, Current diabetes reports.

State of the Art: Islet Transplantation for the Cure of Type 1 Diabetes Mellitus

D. Harlan, K. Rother, B. Hirshberg, 2003, Reviews in Endocrine and Metabolic Disorders.

Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.

J. Gaglia, D. Harlan, K. Rother, 2003, Diabetes care.

Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs

I. Raz, B. Hirshberg, 2011, Diabetes Care.

Efficacy and Toxicity of a Protocol Using Sirolimus, Tacrolimus and Daclizumab in a Nonhuman Primate Renal Allotransplant Model

D. Harlan, A. Kirk, He Xu, 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.

H. Noushmehr, D. Harlan, S. Li Calzi, 2003, Endocrinology.

Hypoglycaemia following pancreatic allograft transplantation.

I. Raz, B. Hirshberg, V. Trelezky, 1998, Journal of internal medicine.

How much insulin is enough? A quantitative assessment of the transdifferentiaton potential of liver

D. Harlan, S. Perl, J. Tisdale, 2007, Diabetologia.

Frequency of cancer events with saxagliptin in the SAVOR‐TIMI 53 trial

Deepak L. Bhatt, Lawrence A Leiter, B. Scirica, 2016, Diabetes, obesity & metabolism.

RABBIT ANTITHYMOCYTE GLOBULIN INDUCTION AND SIROLIMUS MONOTHERAPY SUPPORTS PROLONGED ISLET ALLOGRAFT FUNCTION IN A NONHUMAN PRIMATE ISLET TRANSPLANTATION MODEL

D. Harlan, A. Kirk, He Xu, 2003, Transplantation.

Prevalence and Outcomes of Polyvascular (Coronary, Peripheral, or Cerebrovascular) Disease in Patients With Diabetes Mellitus (From the SAVOR-TIMI 53 Trial).

Marc P. Bonaca, Deepak L. Bhatt, E. Braunwald, 2019, The American journal of cardiology.

The Cardinal Features of Recurrent Autoimmunity in Simultaneous Pancreas-Kidney Transplant Recipients

B. Hirshberg, 2010, Current diabetes reports.

Benefits of simultaneous islet-kidney transplantation versus simultaneous pancreas-kidney transplantation

B. Hirshberg, 2008, Current diabetes reports.

Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression: Response to Charles and Selam

D. Harlan, K. Rother, B. Hirshberg, 2004 .

Yellow nail syndrome 467 Yellow nail syndrome : diagnosis

A. Hershko, B. Hirshberg, M. Nahir, 2003 .

Yellow nail syndrome.

A. Hershko, B. Hirshberg, M. Nahir, 1997, Postgraduate medical journal.

Classic diseases revisited Yellow nail syndrome

A. Hershko, B. Hirshberg, M. Nahir, 1997 .

Effects of cotadutide on biomarkers of non-alcoholic steatohepatitis in overweight or obese subjects with type 2 diabetes mellitus: a 54-week analysis of a randomized phase 2b study

K. Gadde, M. Stumvoll, L. Jermutus, 2020, Journal of Hepatology.

Forty-eight-hour fast: the diagnostic test for insulinoma.

S. Libutti, J. Doppman, P. Gorden, 2000, The Journal of clinical endocrinology and metabolism.

A sustained, non-insulin related, hypoglycaemic effect of electroacupuncture in diabetic Psammomys obesus

E. Ziv, B. Hirshberg, M. Shapira, 2000, Diabetologia.

Preclinical evaluation of tolerance induction protocols and islet transplantation in non‐human primates

D. Harlan, A. Kirk, D. Hale, 2001, Immunological reviews.

6;9 translocation in myelodysplastic syndrome.

B. Hirshberg, M. Shapira, D. Rund, 1999, Cancer genetics and cytogenetics.

Factors predicting mortality of patients with lung abscess.

L. Ben‐Sira, R. Nir-Paz, B. Hirshberg, 1999, Chest.

Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome.

E. Fibach, D. Shouval, D. Ben‐Yehuda, 2000, Journal of hepatology.

Safety of low dose methotrexate in elderly patients with rheumatoid arthritis

A. Rubinow, B. Hirshberg, Mordechi Muszkat, 2000, Postgraduate medical journal.

Effectiveness of Subcutaneous Casirivimab and Imdevimab in Ambulatory Patients with COVID-19

V. Mastey, D. Weinreich, J. Jalbert, 2022, Infectious Diseases and Therapy.

Effectiveness of Subcutaneous Casirivimab and Imdevimab Relative to no COVID-19 Antibody Treatment Among Patients Diagnosed With COVID-19 in the Ambulatory Setting

V. Mastey, D. Weinreich, J. Jalbert, 2022, medRxiv.

Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial

Deepak L. Bhatt, E. Braunwald, B. Scirica, 2016, Diabetes Care.

A Randomized, Double-Blind, Phase 3 Trial of Dapagliflozin Add-on to Saxagliptin plus Metformin in Type 2 Diabetes

C. Mathieu, N. Iqbal, B. Hirshberg, 2015 .

MEDI0382, a GLP‐1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single‐dose, healthy‐subject, randomized, Phase 1 study

L. Jermutus, C. Rondinone, P. Ambery, 2018, British journal of clinical pharmacology.

A Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagli ﬂ ozin Plus Metformin in Patients With Type 2 Diabetes

S. Matthaei, N. Iqbal, B. Hirshberg, 2015 .

Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment–Elevation Myocardial Infarction: Results of REAL-TIMI 63B

Marc P. Bonaca, Michael T. Lu, M. Sabatine, 2022, Circulation.

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

Deepak L. Bhatt, Lawrence A Leiter, E. Braunwald, 2013, The New England journal of medicine.

Chronic eosinophilic pneumonia associated with cutaneous T‐cell lymphoma

M. Lotem, V. Barak, G. Amir, 1999, American journal of hematology.

MEDI0382, a GLP/Glucagon Receptor Dual Agonist, Significantly Reduces Hepatic Fat Content in Subjects with Type 2 Diabetes Mellitus

P. Hockings, P. Ambery, D. Robertson, 2018, Diabetes.

Pancreatic islet transplantation using the nonhuman primate (rhesus) model predicts that the portal vein is superior to the celiac artery as the islet infusion site.

J. Gaglia, D. Harlan, A. Kirk, 2002, Diabetes.

Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital.

B. Hirshberg, M. Kramer, M. Glazer, 1997, Chest.

Esophageal Perforation After Transesophageal Echocardiogram

R. Agid, Y. Caraco, B. Hirshberg, 1999, Echocardiography.

Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using edmonton protocol immunosuppression.

D. Harlan, B. Hirshberg, N. Patterson, 2002, The Journal of clinical endocrinology and metabolism.

Saxagliptin efficacy and safety in patients with type 2 diabetes receiving concomitant statin therapy.

E. Allen, B. Hirshberg, B. Bryzinski, 2014, Journal of diabetes and its complications.

Can we justify living donor islet transplantation?

B. Hirshberg, 2006, Current diabetes reports.

Diurnal thyrotropin secretion in short-term profound primary hypothyroidism: does it ever persist?

J. Veldhuis, N. Sarlis, B. Hirshberg, 2000, Thyroid : official journal of the American Thyroid Association.

Asymptomatic temporary atrioventricular dissociation complicating meningococcal meningitis.

B. Hirshberg, M. Shapira, A. Ben-Yehuda, 1997, International journal of cardiology.

Lessons learned from the International trial of the Edmonton protocol for islet transplantation

B. Hirshberg, 2007, Current diabetes reports.

Recombinant human Lecithin-Cholesterol acyltransferase in patients with atherosclerosis: Phase 2a primary results and phase 2b design.

Marc P. Bonaca, M. Sabatine, D. Morrow, 2021, European heart journal. Cardiovascular pharmacotherapy.

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial

Deepak L. Bhatt, B. Lewis, E. Braunwald, 2014, Circulation.

Renal nitric oxide production during the early phase of experimental diabetes mellitus.

H. Ovadia, I. Raz, A. Iaina, 2000, Kidney international.

Assessment of Human Pancreatic Islet Architecture and Composition by Laser Scanning Confocal Microscopy

Alvin C. Powers, Marcela Brissova, D. Harlan, 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Impact of treatment with saxagliptin on glycaemic stability and β‐cell function in the SAVOR‐TIMI 53 study

Deepak L. Bhatt, W. Sheu, E. Braunwald, 2015, Diabetes, obesity & metabolism.

Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy: A Randomized Double-Blind Trial of Saxagliptin Plus Dapagliflozin Addition Versus Single Addition of Saxagliptin or Dapagliflozin to Metformin

J. Rosenstock, N. Iqbal, Yan Li, 2014, Diabetes Care.

Saxagliptin Efficacy and Safety in Patients with Type 2 Diabetes Mellitus Stratified by Cardiovascular Disease History and Cardiovascular Risk Factors: Analysis of 3 Clinical Trials

B. Hirshberg, Gianmaria Minervini, B. Bryzinski, 2014, Postgraduate medicine.

Saxagliptin improves glycemic control by modulating postprandial glucagon and C-peptide levels in Chinese patients with type 2 diabetes.

N. Iqbal, B. Hirshberg, M. Sjöstrand, 2014, Diabetes research and clinical practice.

Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trials

N. Iqbal, R. Frederich, B. Hirshberg, 2014, Cardiovascular Diabetology.

Lack of mediastinal shift as a clue to delayed postpneumonectomy empyema.

Y. Caraco, B. Hirshberg, M. Shapira, 2000, Southern medical journal.

Natural course of insulin edema

M. Muszkat, T. Marom, M. Muszkat, 2000, Journal of endocrinological investigation.

Challenges in developing endpoints for type 1 diabetes intervention studies

G. A. Fleming, R. Little, K. Herold, 2009, Diabetes/metabolism research and reviews.

Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment

N. Iqbal, B. Hirshberg, W. Cook, 2016, Diabetes Therapy.

Blocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trial

Steven J Novick, Steven J. Novick, J. Falloon, 2021, Science Translational Medicine.

Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c.

Deepak L. Bhatt, Lawrence A Leiter, E. Braunwald, 2016, The American journal of medicine.

Oligonucleotide Microarray Analysis of Intact Human Pancreatic Islets: Identification of Glucose-Responsive Genes and a Highly Regulated TGFβ Signaling Pathway

D. Harlan, J. Brady, C. Pise-Masison, 2002 .

Deepak L. Bhatt, A. Briggs, B. Scirica, 2017, Diabetes research and clinical practice.

Medical cannabis for pain management in patients undergoing chronic hemodialysis: randomized, double-blind, cross-over, feasibility study

N. Vaisman, Ofri Mosenzon, B. Hirshberg, 2022, Clinical kidney journal.

Cardiovascular Outcome Studies With Novel Antidiabetes Agents: Scientific and Operational Considerations

A. Katz, B. Hirshberg, 2013, Diabetes Care.

Safety of low dose methotrexate in elderly patients with rheumatoid arthritis

A. Rubinow, B. Hirshberg, Mordechi Muszkat, 2000, Postgraduate medical journal.

Real-world Effectiveness of Casirivimab and Imdevimab in Patients With COVID-19 in the Ambulatory Setting: An Analysis of Two Large US National Claims Databases

V. Mastey, D. Weinreich, J. Jalbert, 2022, medRxiv.

Clinical Development Approaches and Statistical Methodologies to Prospectively Assess the Cardiovascular Risk of New Antidiabetic Therapies for Type 2 Diabetes

C. Mehta, P. Sager, M. Stewart, 2015, Therapeutic innovation & regulatory science.

Statin and Aspirin Therapy for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus

Deepak L. Bhatt, E. Braunwald, B. Scirica, 2012, Clinical cardiology.

A post hoc analysis of saxagliptin efficacy and safety in patients with type 2 diabetes stratified by UKPDS 10-year cardiovascular risk score.

E. Bonora, B. Hirshberg, B. Bryzinski, 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial

Deepak L. Bhatt, Deepak L Bhatt, Lawrence A Leiter, 2014, Diabetes Care.

MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study

M. Stumvoll, T. Heise, L. Jermutus, 2018, The Lancet.

Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial

Deepak L. Bhatt, E. Braunwald, B. Scirica, 2016, Diabetes Care.

Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk: A Secondary Analysis of a Randomized Clinical Trial.

Deepak L. Bhatt, David A Morrow, Deepak L Bhatt, 2016, JAMA cardiology.

Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes

S. Matthaei, N. Iqbal, B. Hirshberg, 2015, Diabetes Care.

Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes

C. Mathieu, N. Iqbal, B. Hirshberg, 2015, Diabetes Care.

Randomized Trial Heart Failure, Saxagliptin and Diabetes Mellitus: Observations from the SAVOR - TIMI 53

Deepak L. Bhatt, B. Lewis, E. Braunwald, 2014 .

Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical Trials

K. Johnsson, B. Hirshberg, M. Sjöstrand, 2017, Diabetes Therapy.

Assessment of Pancreatic Islet Mass after Islet Transplantation Using In Vivo Bioluminescence Imaging

D. Harlan, E. Jansen, A. Powers, 2005, Transplantation.

Modulation of 11β-Hydroxysteroid Dehydrogenase (11βHSD) Activity Biomarkers and Pharmacokinetics of PF-00915275, a Selective 11βHSD1 Inhibitor

P. Stewart, M. Toh, R. Courtney, 2008 .

Repaglinide-induced factitious hypoglycemia.

P. Gorden, M. Skarulis, G. Csako, 2001, The Journal of clinical endocrinology and metabolism.

354Multiple ascending doses of recombinant human lecithin-cholesterol acyltransferase in patients with atherosclerosis: phase 2a primary results

Marc P. Bonaca, M. Sabatine, D. Morrow, 2018, European Heart Journal.

Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure.

S. Libutti, T. Shawker, H. Alexander, 2002, Journal of the American College of Surgeons.

MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High‐Density Lipoprotein, and Low‐Density Lipoprotein Receptor–Mediated Reverse Cholesterol Transport

R. George, S. Karathanasis, D. She, 2021, Journal of the American Heart Association.

Effects of Glimepiride versus Saxagliptin on β-Cell Function and Hypoglycemia: A Post Hoc Analysis in Older Patients with Type 2 Diabetes Inadequately Controlled with Metformin.

B. Hirshberg, P. Ohman, W. Cook, 2016, Clinical therapeutics.

Modulation of 11beta-hydroxysteroid dehydrogenase (11betaHSD) activity biomarkers and pharmacokinetics of PF-00915275, a selective 11betaHSD1 inhibitor.

P. Stewart, M. Toh, R. Courtney, 2008, The Journal of clinical endocrinology and metabolism.

Achievement of Lipid Targets with the Combination of Rosuvastatin and Fenofibric Acid in Patients with Type 2 Diabetes Mellitus

R. Rosenson, L. Williams, B. Hirshberg, 2010, Cardiovascular Drugs and Therapy.

Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double–Blind Trial

E. Oviedo-Orta, E. Mylonakis, F. Marty, 2023, Open Forum Infectious Diseases.

Is there a therapeutic role for octreotide in patients with ectopic Cushing’s syndrome?

L. Nieman, K. Pacak, G. Uwaifo, 2003, Journal of endocrinological investigation.

Islet transplantation: where do we stand now?

D. Harlan, B. Hirshberg, Kristin Rother, 2003, Diabetes/metabolism research and reviews.

Hypoglycaemia manifestations and recurrent events: Lessons from the SAVOR‐TIMI 53 outcome study

Deepak L. Bhatt, G. Leibowitz, I. Raz, 2017, Diabetes, obesity & metabolism.

Insights From Cardiovascular Outcome Trials with Novel Antidiabetes Agents: What Have We Learned? An Industry Perspective

A. Katz, B. Hirshberg, 2015, Current Diabetes Reports.

Resistin serum levels in type 1 diabetes pre- and post-islet transplantation.

D. Harlan, K. Rother, A. Shalev, 2004, Metabolism: clinical and experimental.

Nesidioblastosis in Adults: A Clinical Enigmag

S. Libutti, H. Alexander, D. Bartlett, 2001 .

Metabolic Function of a Suboptimal Transplanted Islet Mass in Nonhuman Primates on Rapamycin Monotherapy

D. Harlan, M. Rickels, A. Remaley, 2012, Cell transplantation.

Effect of saxagliptin on renal outcome

Deepak L. Bhatt, B. Scirica, G. Leibowitz, 2014 .

A proinsulin gene splice variant with increased translation efficiency is expressed in human pancreatic islets.

D. Harlan, P. Blair, B. Peculis, 2002, Endocrinology.

Abstract 17503: Outcomes of Patients With Type 2 Diabetes and Known Congestive Heart Failure Treated With Saxagliptin: Analyses of the SAVOR-TIMI 53 Study

Deepak L. Bhatt, E. Braunwald, B. Scirica, 2013 .

Randomised, phase 1, dose-finding study of MEDI4166, a PCSK9 antibody and GLP-1 analogue fusion molecule, in overweight or obese patients with type 2 diabetes mellitus

L. Morrow, G. Carlson, P. Ambery, 2018, Diabetologia.

Erratum. Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study. Diabetes Care 2021;44:1433-1442.

K. Gadde, M. Stumvoll, L. Jermutus, 2022, Diabetes care.

Oligonucleotide microarray analysis of intact human pancreatic islets: identification of glucose-responsive genes and a highly regulated TGFbeta signaling pathway.

C. Pise-Masison, M. Radonovich, B. Hirshberg, 2002, Endocrinology.

PROGNOSTIC IMPLICATIONS OF SIMULTANEOUS BIOMARKER ASSESSMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: OBSERVATIONS FROM THE SAVOR-TIMI 53 TRIAL

Deepak L. Bhatt, E. Braunwald, D. Morrow, 2014 .

The design and rationale of the saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI) 53 study.

Deepak L. Bhatt, E. Braunwald, B. Scirica, 2011, American heart journal.

Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial.

B. Joondeph, J. Pearlman, C. Wykoff, 2023, JAMA ophthalmology.